Clinical Trial

Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated January 23, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this research study is to see the outcome of Sugammadex versus Neostigmine with Glycopyrrolate in colorectal surgery as it relates to its effects on post-surgical time (in hours) to first bowel movement and tolerance for solid food (GI-2 recovery) following bowel resection surgery
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-10-31; most recent amendment 2026-01-21.
Status change: Not Yet Recruiting → Recruiting 2024-08-05
Trial Details
NCT Number NCT06112353
Lead Sponsor University of California, Irvine
Collaborators: Merck Sharp & Dohme LLC
Conditions Intestinal Disease
Enrollment 128 participants
Start Date 2024-04-17
Primary Completion 2026-07 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-23